Catecholamine levels with use of electronic and combustible cigarettes.

Autor: Poudel R; American Heart Association, Dallas, United States., Li S; American Heart Association, Dallas, United States., Hong H; American Heart Association, Dallas, United States., Zhao J; American Heart Association, Dallas, United States., Srivastava S; Department of Medicine, Envirome Institute, University of Louisville, Louisville, United States., Robertson RM; American Heart Association, Dallas, United States., Hall JL; American Heart Association, Dallas, United States., Srivastava S; Department of Medicine, Envirome Institute, University of Louisville, Louisville, United States., Hamburg NM; Whitaker Cardiovascular Institute, Chobanian & Avedisian School of Medicine, Boston University, Boston, United States., Bhatnagar A; Department of Medicine, Envirome Institute, University of Louisville, Louisville, United States., Keith RJ; Department of Medicine, Envirome Institute, University of Louisville, Louisville, United States.
Jazyk: angličtina
Zdroj: Tobacco induced diseases [Tob Induc Dis] 2024 Aug 14; Vol. 22. Date of Electronic Publication: 2024 Aug 14 (Print Publication: 2024).
DOI: 10.18332/tid/190687
Abstrakt: Introduction: Smoking elevates catecholamines that increase the risk for cardiovascular disease. Sparse evidence exists about the effects of e-cigarettes and catecholamines. Higher levels of catecholamines could trigger the increased heart rate, blood pressure, and decreased vascular function reported with the use of e-cigarettes. We investigated the difference in urinary catecholamines and their metabolites before and after the use of an e-cigarette containing nicotine or cigarettes compared to no tobacco use.
Methods: In our observational cohort exposure study, healthy adults aged 21-45 years who were currently using e-cigarettes, cigarettes, or had never used tobacco, participated in an acute exposure visit using their most common tobacco product. Urine was collected before, 1, and 2 hours after a 3-second puff every 30 seconds for 10 minutes on an e-cigarette or straw or use of 1 cigarette. Urinary catecholamines and their metabolites were measured by ultra-high-performance liquid chromatography. Participants (n=323) were grouped by the product used at the visit. We compared levels of creatinine normalized log-transformed urinary catecholamines and their metabolites across groups using Dunn's test following a Kruskal-Wallis test in unadjusted and demographically adjusted models.
Results: Prior to use, individuals who used cigarettes (n=70) had lower urinary metabolites from epinephrine, serotonin, and norepinephrine. No differences were seen in those who used e-cigarettes (n=171) and those who did not use tobacco (n=82). In fully adjusted models, 1 h after the use of a combustible or e-cigarette, log-transformed urinary metabolites from norepinephrine (β=1.22; 95% CI: 0.39-2.05, p=0.004 and β=1.06; 95% CI: 0.39-1.74, p=0.002), dopamine (β=0.37; 95% CI: 0.24-0.5, p<0.001 and β=0.15; 95% CI: 0.05-0.26, p<0.001), and epinephrine (β=1.89; 95% CI: 0.51-3.27, p=0.008 and β=1.49; 95% CI: 0.38-2.61, p=0.009) were elevated. In fully adjusted models, combustible cigarette use was associated with elevated urinary norepinephrine (β=0.46; 95% CI: 0.13-0.81, p=0.007) and dopamine (β=0.19; 95% CI: 0.06-0.31, p=0.003) 1 h after use.
Conclusions: We found that the use of both e-cigarettes and cigarettes was associated with elevated urinary catecholamines or their metabolites. Catecholamines could be useful as a biomarker of harm for tobacco use and considered by tobacco regulatory scientists in future research.
Competing Interests: The authors have each completed and submitted an ICMJE form for Disclosure of Potential Conflicts of Interest. The authors declare that they have no competing interests, financial or otherwise, related to the current work. R.M. Robertson reports that since the initial planning of the work, her organization (AHA) received the following grants: U54 HL120163 2018-2023 (NIH/FDA) and P50 HL120163 2012-2017 (NIH/ FDA). She also reports that in the past 36 months she received support for attending meetings and travel from the American Heart Association (AHA) and Robert Wood Johnson Foundation (RWJF), and that she was a Member and then Chair of the National Advisory Committee for the RWJF’s Harold Amos Medical Faculty Development Program (HAMFDP).
(© 2024 Poudel R. et al.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje